SpectraCure AB (publ) (STO:SPEC)

Market Cap	43.34M -82.0%
Revenue (ttm)	n/a
Net Income	-53.17M
EPS	-0.26
Shares Out	409.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	549,043
Average Volume	2,261,532
Open	0.1012
Previous Close	0.1058
Day's Range	0.0980 - 0.1054
52-Week Range	0.0850 - 3.6000
Beta	0.46
RSI	41.15
Earnings Date	Feb 20, 2026

About SpectraCure AB

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 13
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SPEC